Mitochondrial oxidant signalling in Alzheimer's disease

被引:0
|
作者
Vina, Jose [1 ]
Lloret, Ana [1 ]
Valles, Soraya L. [1 ]
Borras, Consuelo [1 ]
Badia, Mari-Carmen [1 ]
Pallardo, Federico V. [1 ]
Sastre, Juan [1 ]
Alonso, Maria-Dolores [1 ]
机构
[1] Fac Med, Dept Fisiol, Valencia 46010, Spain
关键词
apoptosis; gender; estrogenic compounds; antioxidants; MAP kinases;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The role of free radicals in Alzheimer disease pathophysiology has been appreciated for a long time. Originally, radicals were considered as causative of oxidative damage. More recently their role as signalling molecules in this, as well as in other fields of free radical biology, has been underscored. Mitochondria are both generators and targets of radical damage in aging. In this paper we review evidence that radicals generated in mitochondria in the presence of A beta are signals that trigger both the mitochondrial and the extra-mitochondrial pathways of apoptosis. There are gender specific differences in mitochondrial A beta toxicity: mitochondria from young (but not from old) females appear to be protected. 17-beta Estradiol or phytoestrogens like genistein prevent the formation of oxidants by mitochondria and protect against mitochondrial A beta toxicity. Experiments reported here indicate that phytoestrogens might have a role in the prevention of Alzheimer's disease.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 50 条
  • [1] Endocannabinoid signalling in Alzheimer's disease
    Maroof, Nazia
    Pardon, Marie Christine
    Kendall, David A.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2013, 41 : 1583 - 1587
  • [2] Survival signalling in Alzheimer's disease
    Lukiw, W. J.
    Bazan, N. G.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2006, 34 : 1277 - 1282
  • [3] Calcium Signalling and Alzheimer’s Disease
    Michael J. Berridge
    Neurochemical Research, 2011, 36 : 1149 - 1156
  • [4] Calcium Signalling and Alzheimer's Disease
    Berridge, Michael J.
    NEUROCHEMICAL RESEARCH, 2011, 36 (07) : 1149 - 1156
  • [5] PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease
    Du, Fang
    Yu, Qing
    Yan, Shijun
    Hu, Gang
    Lue, Lih-Fen
    Walker, Douglas G.
    Wu, Long
    Yan, Shi Fang
    Tieu, Kim
    Yan, Shirley ShiDu
    BRAIN, 2017, 140 : 3233 - 3251
  • [6] Glial Calcium Signalling in Alzheimer's Disease
    Lim, Dmitry
    Ronco, Virginia
    Grolla, Ambra A.
    Verkhratsky, Alexei
    Genazzani, Armando A.
    REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 167, 2014, 167 : 45 - 65
  • [7] Adenosine receptor signalling in Alzheimer's disease
    Trinh, Phuc N. H.
    Baltos, Jo-Anne
    Hellyer, Shane D.
    May, Lauren T.
    Gregory, Karen J.
    PURINERGIC SIGNALLING, 2022, 18 (03) : 359 - 381
  • [8] Oxidant/Antioxidant Imbalance and the Risk of Alzheimer's Disease
    Abdel Moneim, Ahmed E.
    CURRENT ALZHEIMER RESEARCH, 2015, 12 (04) : 335 - 349
  • [9] Adenosine receptor signalling in Alzheimer’s disease
    Phuc N. H. Trinh
    Jo-Anne Baltos
    Shane D. Hellyer
    Lauren T. May
    Karen J. Gregory
    Purinergic Signalling, 2022, 18 : 359 - 381
  • [10] Astroglial calcium signalling in Alzheimer's disease
    Verkhratsky, Alexei
    Rodriguez-Arellano, J. J.
    Parpura, Vladimir
    Zorec, Robert
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 483 (04) : 1005 - 1012